Related Experiment Videos
beta-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology
C J Pike1, B J Cummings, C W Cotman
1Department of Psychobiology, University of California, Irvine 92717.
Abstract:
beta-Amyloid protein, the major component of neuritic plaques found in Alzheimer's disease, has been implicated as a potential contributor to the disease's progressive neuropathology. We report that within a two day exposure to aggregates of synthetic beta-amyloid peptide, the neurites of cultured rat hippocampal neurons adopt a dystrophic appearance. Observed morphological changes in the neurites include beading, fragmentation, terminal swelling and tortuous growth patterns. The degenerative changes are similar to those observed in neurites associated with neuritic plaques, suggesting that beta-amyloid may induce the neuritic abnormalities of Alzheimer neuropathology.
Insights
Synthetic beta-amyloid peptide aggregates cause neuritic abnormalities in cultured rat hippocampal neurons within two days. These changes mimic those seen in Alzheimer's disease, suggesting beta-amyloid's role in neuropathology.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Beta-amyloid protein is a key component of neuritic plaques in Alzheimer's disease.
- Its role in progressive neuropathology is under investigation.
Purpose of the Study:
- To investigate the effect of synthetic beta-amyloid peptide aggregates on neuronal morphology.
- To determine if beta-amyloid can induce neuritic abnormalities similar to those in Alzheimer's disease.
Main Methods:
- Cultured rat hippocampal neurons were exposed to synthetic beta-amyloid peptide aggregates.
- Neurite morphology was observed over a two-day period.
Main Results:
- Exposure to beta-amyloid aggregates induced dystrophic changes in neuronal neurites.
- Observed changes included beading, fragmentation, terminal swelling, and tortuous growth patterns.
Conclusions:
- Synthetic beta-amyloid peptide can induce neuritic abnormalities in vitro.
- These findings suggest a potential mechanism by which beta-amyloid contributes to Alzheimer's neuropathology.